Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 2011

View Archived Issues

Eisai's Halaven injection approved in Singapore for metastatic breast cancer

Cardiac imaging using [123I]-mIBG can predict development of permanent atrial fibrillation

Dextran-coated iron oxide nanoparticles detect cholera enterotoxin with high sensitivity

Homocysteine level in serum is a biomarker for extent of vitiligo

Aptamer-targeted nanoparticle-encapsulated cisplatin prodrug shows promise in vivo

New inverse agonist of RAR-related orphan receptor-alpha SR-3335 improves glucose homeostasis

BioAlliance Pharma reports preliminary data from survey in patients with herpes labialis

PolyMedix begins phase II trial of PMX-60056 for reversal of heparin action in surgical setting

Teva Pharma reports phase III data on Qnaze in perennial allergic rhinitis

Novel urotensin UT receptor antagonists claimed by sanofi-aventis

CeNeRx presents first-in-human results on CXB-909

Cytokinetics and Amgen divulge design of phase IIb trial of intravenous omecamtiv mecarbil

Cephalon and Alba Therapeutics enter option agreement for larazotide acetate

GeoVax opens second site for ongoing HIV vaccine trial

First patient treated in CMV-ACE/ASPECT trial of preemptive cell therapy for CMV infection

Amicus Therapeutics begins phase II trial of Amigal plus ERT in Fabry's disease

European orphan drug status recommended for QLT-091001 in LCA and RP

Evotec enters definitive agreement to acquire Kinaxo Biotechnologies

Anacor and Medicis to collaborate on development of acne treatments

Futura Medical and Ansell enter commercialization agreement for PET-500

Eisai and Bial launch antiepileptic Zebinix in Spain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...